Boehringer Ingelheim chooses Creon Lab Control's Q-Dis/Panda web-based central storage system for its electronic record management solution
Creon Lab Control has announced it has received a corporate license order for Q-Dis/Panda software and services from Boehringer Ingelheim, one of the 20 leading pharmaceutical corporations in the world.
Q-Dis/Panda is a platform-independent, 100% web-based central storage system, which harvests all kinds of widely dispersed information (electronic records) to generate a powerful knowledge-based corporate archive.
Boehringer Ingelheim has been using Creon Lab Control software solutions for seven years.
Starting as a development partner for Q-Dis/AQV it has helped to optimise the specification management of analytical testing methods as well as increasing productivity by using the Q-Dis/QM Lims and Q-Dis/R analytical R and D workflow system. With the new product Q-Dis/Panda, Boehringer Ingelheim is strengthening its commitment to Creon Lab Control solutions. Boehringer Ingelheim plans to lever the Q-Dis/Panda software solution for electronic record management and corporate archiving especially within R and D and production.
"Once again, Creon Lab Control has demonstrated ability to help customers improve their entire product development processes," said Daniela Weber, sales director.
"By using the breadth of Creon Lab Control's software solutions, Boehringer Ingelheim is able to create innovative products in a collaborative environment and control, store as well as retrieve the data for later reuse.
We are pleased to expand our partnership with Boehringer Ingelheim and to continue to deliver quality products and services."
